Gigaxonin Suppresses Epithelial-to-Mesenchymal Transition of Human Cancer Through Downregulation of Snail

Author:

Veena Mysore S.1ORCID,Gahng Jungmo J.1ORCID,Alani Mustafa1ORCID,Ko Albert Y.1ORCID,Basak Saroj K.1ORCID,Liu Isabelle Y.1ORCID,Hwang Kimberly J.1ORCID,Chatoff Jenna R.1ORCID,Venkatesan Natarajan1ORCID,Morselli Marco2ORCID,Yan Weihong3ORCID,Ali Ibraheem4ORCID,Kaczor-Urbanowicz Karolina Elżbieta56ORCID,Gowda Bhavani Shankara1ORCID,Frost Patrick7ORCID,Pellegrini Matteo2ORCID,Moatamed Neda A.8ORCID,Wilczynski Sharon P.9ORCID,Bomont Pascale10ORCID,Wang Marilene B.11ORCID,Shin Daniel Sanghoon7ORCID,Srivatsan Eri S.1ORCID

Affiliation:

1. 1Department of Surgery, VAGLAHS/David Geffen School of Medicine at UCLA, Los Angeles, California.

2. 2Department of Molecular, Cellular and Developmental Biology, UCLA, Los Angeles, California.

3. 3Department of Chemistry and Biochemistry and the Institute for Quantitative and Computational Biology, UCLA, Los Angeles, California.

4. 4Department of Louise M. Darling Biomedical Library and The Institute for Quantitative and Computational Biology, UCLA, Los Angeles, California.

5. 5Department of Oral Biology and Medicine, Center for Oral and Head/Neck Oncology Research, School of Dentistry, UCLA, Los Angeles, California.

6. 6The Institute for Quantitative and Computational Biosciences, UCLA, Los Angeles, California.

7. 7Department of Medicine, VAGLAHS/David Geffen School of Medicine at UCLA, Los Angeles, California.

8. 8Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California.

9. 9Department of Pathology, City of Hope National Medical Center, Duarte, California.

10. 10ERC team, INMG, UCBL Lyon1 – CNRS UMR5261 – INSERM U1315, Université Lyon 1, Université de Lyon, Lyon, France.

11. 11Department of Surgery, VAGLAHS and Department of Head and Neck Surgery, David Geffen School of Medicine at UCLA, Los Angeles, California.

Abstract

Abstract Gigaxonin is an E3 ubiquitin ligase that plays a role in cytoskeletal stability. Its role in cancer is not yet clearly understood. Our previous studies of head and neck cancer had identified gigaxonin interacting with p16 for NFκB ubiquitination. To explore its role in cancer cell growth suppression, we analyzed normal and tumor DNA from cervical and head and neck cancers. There was a higher frequency of exon 8 SNP (c.1293 C>T, rs2608555) in the tumor (46% vs. 25% normal, P = 0.011) pointing to a relationship to cancer. Comparison of primary tumor with recurrence and metastasis did not reveal a statistical significance. Two cervical cancer cell lines, ME180 and HT3 harboring exon 8 SNP and showing T allele expression correlated with higher gigaxonin expression, reduced in vitro cell growth and enhanced cisplatin sensitivity in comparison with C allele expressing cancer cell lines. Loss of gigaxonin expression in ME180 cells through CRISPR-Cas9 or siRNA led to aggressive cancer cell growth including increased migration and Matrigel invasion. The in vitro cell growth phenotypes were reversed with re-expression of gigaxonin. Suppression of cell growth correlated with reduced Snail and increased e-cadherin expression. Mouse tail vein injection studies showed increased lung metastasis of cells with low gigaxonin expression and reduced metastasis with reexpression of gigaxonin. We have found an association between C allele expression and RNA instability and absence of multimeric protein formation. From our results, we conclude that gigaxonin expression is associated with suppression of epithelial–mesenchymal transition through inhibition of Snail. Significance: Our results suggest that GAN gene exon 8 SNP T allele expression correlates with higher gigaxonin expression and suppression of aggressive cancer cell growth. There is downregulation of Snail and upregulation of e-cadherin through NFκB ubiquitination. We hypothesize that exon 8 T allele and gigaxonin expression could serve as diagnostic markers of suppression of aggressive growth of head and neck cancer.

Funder

VA | VA Greater Los Angeles Healthcare System

Publisher

American Association for Cancer Research (AACR)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3